Why Novavax Stock Is Skyrocketing Today
Novavax lands a massive $1.6 billion award from the federal government's Operation Warp Speed program.
Why Heron Therapeutics Stock Is Tanking Today
Its non-opioid painkiller gets a rejection over non-clinical issues.
Why Intercept Pharmaceuticals Stock Is Crashing Today
Shares are taking a step back after the FDA rejected the company's NASH candidate.
2 Top Healthcare Stocks to Watch in June
Heron Therapeutics and Novavax are two key healthcare stocks to watch this month.
Why Adaptimmune Therapeutics Stock Crushed It in May
The biotech continued its winning ways.
2 Top Pharma Stocks to Buy in June
Bristol Myers Squibb and Pfizer are two of the safest stocks investors can buy right now.
Why Agenus Stock Took Flight in May
The immunotherapy company may be a diamond in the rough.
Why Novavax Stock Is Up Big Yet Again Today
Novavax scores another large grant for its COVID-19 vaccine candidate.
Why Minerva Neurosciences Is Heading Higher Today
The biotech's shares are mounting a modest comeback after their ugly decline on Friday.
Why Adaptimmune Therapeutics Stock Sank and Then Quickly Rebounded Today
Adaptimmune prudently decided to take advantage of its soaring share price to raise capital.
Why Evofem Biosciences Stock Is on Fire Today
Evofem Biosciences scored a major regulatory win last Friday.
Why Novavax Stock Is Skyrocketing Tuesday
Novavax's experimental COVID-19 vaccine has officially entered an early-stage trial.
Why Dynavax Technologies Is Jumping Today
Dynavax's COVID-19 vaccine program is turning heads this morning.
Why Novavax Is Blasting Higher Today
The clinical biotech is benefiting from an analyst upgrade and optimism about its pipeline.
Why Aurora Cannabis Stock Is Soaring Today
The marijuana specialist's better-than-expected third-quarter 2020 earnings report has investors excited.
Why Sorrento Therapeutics Stock Is on Fire Today
Sorrento's shares are continuing their surge from last Friday. Here's why.
Why Aphria's Stock Crushed It in April
Aphria's shares surged higher last month on the heels of a strong Q3 report.
Why Clovis Oncology Stock Marched Higher in April
Clovis Oncology's stock reversed course last month.
Why MyoKardia Stock Is on Fire Today
The company's experimental heart drug hit the mark in a pivotal study.
Why DexCom Stock Rocketed Higher in April
DexCom's shares have been crushing it of late.